Rating History for Kinnate Biopharma (KNTE) by Wedbush

More Stocks Rated by Wedbush | Latest Ratings for KNTE
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
9/19/2023 David Nierengarten Downgrade Neutral
(Outperform)		 2.00
(14.00)		 1.70
(2.65)		 55.88% Details